COVID-19: "These" Vaccines Get Restricted Emergency Use Authorisation, Claim Reports
by Suraj V. Digital Marketing (sr. SEO Expert)On Tuesday, April 26, a report by
the news agency ANI, claimed that the Drugs Controller General of India (DCGI)
has accorded restricted emergency use authorisation to Bharat
Biotech's COVID-19 vaccine, Covaxin
for children between the age of 6-12 years.
On the other hand, the agency
also reported that the DCGI granted emergency
use authorisation to Corbevax as well for children between 5-12 years.
In addition to this, the
narrative claims that the body has also granted emergency use
authorisation to ZycovD (Zydus Cadila vaccine) for children over the age of 12
years.
These developments come at a day
when India reported 2,483 fresh coronavirus cases
and 1,970 recoveries. Similarly, the active cases stood at 15,636.
Similarly, the threat of the
fourth wave looms throughout the country. Considering this phenomenon, several
states and union territories such as Punjab, Delhi, Haryana, Uttar Pradesh,
Karnataka and Chhattisgarh, have brought back the mask mandate. However, masks continue to remain
voluntary in Maharashtra.
Further commenting on the
possible fourth wave, Dr. Gowri Kulkarni, Head of Operations, MediBuddy
remarks, "With the uptick of fresh cases of COVID-19 in India, the
authorities are implementing the protection protocols again. The rise of new
cases in India is owing to the voluntary usage of masks. With the celebration
of festivals, increase in people movement, and poor adherence to COVID
protocols, the probability of another wave is high. However, there is no need
to panic at this moment."
Kulkarni recommends certain protocols that include:
- Use of mask
- COVID-19 appropriate behaviour
- Vaccination and booster shots
She concludes, "With an
increase in vaccination and booster reach, probably the expected 4th wave of
COVID would be lower in its severity and peak."
Sponsor Ads
Created on Apr 26th 2022 06:38. Viewed 192 times.